Latest Update:

  • 📢 Upcoming New Batches – April

  • Clinical Research:  New batch begins on 20 April at 07:00 PM..

  • Pharmacovigilance:  New batch begins on 18 April at 05:00 PM...

  • CDM:  New batch begins on 20 April at 05:30 PM..

  • DSP: New batch begins on 27 April at 08:00 PM...

  • Medical Writing: New batch begins on 21 April at 07:00 PM...

  • Regulatory Affairs: New batch begins on 28 April  at 07:00 PM...

+917022425292
Inquire Now

Pharmacovigilance Interview Q&A Series

Subscribe Now
YouTube Video UExWTjl2RlluMURpb0huYlpaSlVwWWhOTG5fS3dvSFVHUC41NkI0NEY2RDEwNTU3Q0M2 Pharmacovigilance Interview | Adverse Drug Reaction | Adverse Drug Events | Drug Side Effects To Contact Us - https://links.careerinpharma.com/inquiry For further information click here - https://links.careerinpharma.com/profile Embark on a knowledge journey in the realm of Pharmacovigilance with our insightful Pharmacovigilance Interview Q&A Series – Episode 1! Dr. Neema Bisht intricately navigates through the concepts of Adverse Drug Reactions, Adverse Drug Events, and Side Effects, providing a comprehensive understanding of their distinctions. Gain valuable insights that will not only enhance your knowledge base but also prepare you for Pharmacovigilance interviews. Join us in decoding the complexities of drug safety and usher in a new era of learning! Mail: connect@careerinpharma.com Website: https://careerinpharma.com To Join our Masterclass: https://linktr.ee/careerinpharma Join our Telegram Channel: https://t.me/careerinpharma Follow us on Instagram: https://instagram.com/careerinpharma Facebook Group: https://www.facebook.com/profile.php?id=100077386143393 LinkedIn: https://www.linkedin.com/in/dr-neema-bisht-2ab2756b Timestamps 00:00 - Introduction 00:53 - ADR, ADE & Side Effects 01:42 - Adverse drug reaction 05:47 - Example of ADR 06:53 - Adverse drug event 09:07 - ADR vs ADE 09:52 - Example of ADE 12:02 - Side effects 16:17 - Conclusion
Pharmacovigilance Interview | Adverse Drug Reaction | Adverse Drug Events | Drug Side Effects
February 3, 2024 3:00 pm
Pharmacovigilance Interview | Adverse Drug Reaction | Adverse Drug Events | Drug Side Effects To Contact Us - https://links.careerinpharma.com/inquiry For further information click here - https://links.careerinpharma.com/profile Embark on a knowledge journey in the realm of Pharmacovigilance with our insightful Pharmacovigilance Interview Q&A Series – Episode 1! Dr. Neema Bisht intricately navigates through the concepts of Adverse Drug Reactions, Adverse Drug Events, and Side Effects, providing a comprehensive understanding of their distinctions. Gain valuable insights that will not only enhance your knowledge base but also prepare you for Pharmacovigilance interviews. Join us in decoding the complexities of drug safety and usher in a new era of learning! Mail: connect@careerinpharma.com Website: https://careerinpharma.com To Join our Masterclass: https://linktr.ee/careerinpharma Join our Telegram Channel: https://t.me/careerinpharma Follow us on Instagram: https://instagram.com/careerinpharma Facebook Group: https://www.facebook.com/profile.php?id=100077386143393 LinkedIn: https://www.linkedin.com/in/dr-neema-bisht-2ab2756b Timestamps 00:00 - Introduction 00:53 - ADR, ADE & Side Effects 01:42 - Adverse drug reaction 05:47 - Example of ADR 06:53 - Adverse drug event 09:07 - ADR vs ADE 09:52 - Example of ADE 12:02 - Side effects 16:17 - Conclusion
Pharmacovigilance Interview | Adverse Drug Reaction | Adverse Drug Events | Drug Side Effects
YouTube Video UExWTjl2RlluMURpb0huYlpaSlVwWWhOTG5fS3dvSFVHUC41NkI0NEY2RDEwNTU3Q0M2

Pharmacovigilance Interview | Adverse Drug Reaction | Adverse Drug Events | Drug Side Effects

CareerInPharma February 3, 2024 3:00 pm

History & Development of Pharmacovigilance|Pharmacovigilance Interview|History of Pharmacovigilance To Contact Us - https://links.careerinpharma.com/inquiry For further information click here - https://links.careerinpharma.com/profile Delve into the intriguing history and global development of Pharmacovigilance with Episode 2 of our exclusive series. Dr. Neema Bisht navigates through pivotal moments, from international milestones like the Sulfanilamide Elixir Disaster to India's progressive strides in drug safety. Gain insights into the evolution of regulatory bodies like WHO, EMA, and India's Drug Controller General, shaping the landscape of pharmacovigilance. Unravel the past to understand the present and future of drug safety. Tune in now! Mail: connect@careerinpharma.com Website: https://careerinpharma.com To Join our Masterclass: https://linktr.ee/careerinpharma Join our Telegram Channel: https://t.me/careerinpharma Follow us on Instagram: https://instagram.com/careerinpharma Facebook Group: https://www.facebook.com/profile.php?id=100077386143393 LinkedIn: https://www.linkedin.com/in/dr-neema-bisht-2ab2756b Timestamps 00:00 - Introduction 00:52 - History of Pharmacovigilance 04:10 - Pharmacovigilance - International 04:29 - Sulfanilamide Elixir Disaster 06:52 - Thalidomide Diasater 10:18 - WHO Program for International Drug Monitoring 10:52 - European Medicine Agency (EMA) 11:19 - EudraVigilance 12:39 - Pharmacovigilance - India 12:50 - Drug Controller General of India 13:42 - National Program of Pharmacovigilance 15:03 - Indian Pharmacopoeia Commission (IPC) 19:17 - Conclusion
History & Development of Pharmacovigilance|Pharmacovigilance Interview|History of Pharmacovigilance
YouTube Video UExWTjl2RlluMURpb0huYlpaSlVwWWhOTG5fS3dvSFVHUC4yODlGNEE0NkRGMEEzMEQy

History & Development of Pharmacovigilance|Pharmacovigilance Interview|History of Pharmacovigilance

CareerInPharma February 7, 2024 3:00 pm

Good Pharmacovigilance Practice|Pharmacovigilance Interview|What is Good Pharmacovigilance Practice? To Contact Us - https://links.careerinpharma.com/inquiry For further information click here - https://links.careerinpharma.com/profile Unlock the insights into Good Pharmacovigilance Practice (GVP) with Dr. Neema in the latest episode of our Pharmacovigilance Interview Q&A series! Gain comprehensive insights into the significance of GVP and its pivotal modules, including the 6th module, as we unravel the essence of pharmacovigilance excellence. Don't miss out on this invaluable opportunity to elevate your knowledge and expertise! Mail: connect@careerinpharma.com Website: https://careerinpharma.com To Join our Masterclass: https://linktr.ee/careerinpharma Join our Telegram Channel: https://t.me/careerinpharma Follow us on Instagram: https://instagram.com/careerinpharma Facebook Group: https://www.facebook.com/profile.php?id=100077386143393 LinkedIn: https://www.linkedin.com/in/dr-neema-bisht-2ab2756b Timestamps 00:00 - Introduction 00:45 - Good Pharmacovigilance practise (GVP) 06:19 - GVP modules 11:51 - GVP 6th module 18:25 - Conclusion
Good Pharmacovigilance Practice| Pharmacovigilance Interview| Adverse Drug Reaction
YouTube Video UExWTjl2RlluMURpb0huYlpaSlVwWWhOTG5fS3dvSFVHUC4wMTcyMDhGQUE4NTIzM0Y5

Good Pharmacovigilance Practice| Pharmacovigilance Interview| Adverse Drug Reaction

CareerInPharma February 10, 2024 3:00 pm

Types of Adverse Drug Reactions | Pharmacovigilance Interview | Types of ADR |Adverse Drug Reactions To Contact Us - https://links.careerinpharma.com/inquiry For further information click here - https://links.careerinpharma.com/profile Embark on a comprehensive journey through the complexities of adverse drug reactions (ADRs) in Episode 4 of our Pharmacovigilance Interview Q&A Series, hosted by Dr. Neema Bisht! Delve into the multifaceted classifications of ADRs, exploring their diverse nature and severity levels. From Type A to F categorizations, to understanding ADR severity, this episode offers invaluable insights into the realm of pharmacovigilance. Join us for an enlightening discussion that illuminates the crucial facets of drug safety and pharmacological monitoring. Don't miss out on this enriching exploration! Mail: connect@careerinpharma.com Website: https://careerinpharma.com To Join our Masterclass: https://linktr.ee/careerinpharma Join our Telegram Channel: https://t.me/careerinpharma Follow us on Instagram: https://instagram.com/careerinpharma Facebook Group: https://www.facebook.com/profile.php?id=100077386143393 LinkedIn: https://www.linkedin.com/in/dr-neema-bisht-2ab2756b Timestamps 00:00 - Introduction 01:37 - Adverse drug reaction 02:22 - Classification of ADR (Nature of drug) 04:12 - Type A - Augmented 06:58 - Type B - Bizarre 08:33 - Type C - Chronic 10:14 - Type D - Delayed 11:21 - Type E - End of Use 13:06 - Type F - Failure of Treatment 14:24 - Classification of ADR (Severity) 14:39 - Mild ADR 14:47 - Moderate ADR 15:03 - Severe ADR 15:50 - Conclusion
Types of Adverse Drug Reactions | Pharmacovigilance Interview | Types of ADR |Adverse Drug Reactions
YouTube Video UExWTjl2RlluMURpb0huYlpaSlVwWWhOTG5fS3dvSFVHUC41MjE1MkI0OTQ2QzJGNzNG

Types of Adverse Drug Reactions | Pharmacovigilance Interview | Types of ADR |Adverse Drug Reactions

CareerInPharma February 14, 2024 3:00 pm

Serious Adverse Event | Pharmacovigilance Interview | Types of Serious Adverse Events To Contact Us - https://links.careerinpharma.com/inquiry For further information click here - https://links.careerinpharma.com/profile Dive into the intricacies of Serious Adverse Events (SAE) with Episode 4 of our Pharmacovigilance Interview Q&A series! Dr. Neema simplifies the classification and criteria for identifying SAEs, accompanied by insightful case scenarios. Gain valuable insights into this critical aspect of pharmacovigilance. Don't miss out on this informative session! Mail: connect@careerinpharma.com Website: https://careerinpharma.com To Join our Masterclass: https://linktr.ee/careerinpharma Join our Telegram Channel: https://t.me/careerinpharma Follow us on Instagram: https://instagram.com/careerinpharma Facebook Group: https://www.facebook.com/profile.php?id=100077386143393 LinkedIn: https://www.linkedin.com/in/dr-neema-bisht-2ab2756b Timestamps 00:00 - Introduction 01:08 - Serious adverse event (SAE) 02:47 - Criterion for Serious adverse event 07:07 - SAE examples (Case scenarios) 12:33 - Conclusion
Serious Adverse Event | Pharmacovigilance Interview | Types of Serious Adverse Events
YouTube Video UExWTjl2RlluMURpb0huYlpaSlVwWWhOTG5fS3dvSFVHUC4wOTA3OTZBNzVEMTUzOTMy

Serious Adverse Event | Pharmacovigilance Interview | Types of Serious Adverse Events

CareerInPharma February 17, 2024 3:00 pm

Serious Adverse Event | Severe Adverse Event | CTCAE | Severe Adverse Event Reporting |Adverse Event To Contact Us - https://links.careerinpharma.com/inquiry For further information click here - https://links.careerinpharma.com/profile Delve into the intricate world of adverse event evaluation with Episode 6 of our Pharmacovigilance Interview Q&A Series! Join Dr. Neema Bisht as she elucidates the distinctions between seriousness and severity, unraveling the complexities of the CTCAE grading system. Gain invaluable insights into reporting severe adverse events and enhancing your pharmacovigilance acumen. Don't miss out on this enlightening discussion! Mail: connect@careerinpharma.com Website: https://careerinpharma.com To Join our Masterclass: https://linktr.ee/careerinpharma Join our Telegram Channel: https://t.me/careerinpharma Follow us on Instagram: https://instagram.com/careerinpharma Facebook Group: https://www.facebook.com/profile.php?id=100077386143393 LinkedIn: https://www.linkedin.com/in/dr-neema-bisht-2ab2756b Timestamps 00:00 - Introduction 00:48 - Seriousness vs Severity 01:53 - Severity of adverse event 02:57 - Seriousness of adverse event 03:49 - CTCAE Grading System 06:48 - Conclusion
Serious Adverse Event | Severe Adverse Event | CTCAE | Severe Adverse Event Reporting |Adverse Event
YouTube Video UExWTjl2RlluMURpb0huYlpaSlVwWWhOTG5fS3dvSFVHUC4xMkVGQjNCMUM1N0RFNEUx

Serious Adverse Event | Severe Adverse Event | CTCAE | Severe Adverse Event Reporting |Adverse Event

CareerInPharma February 21, 2024 3:00 pm

Load More... Subscribe